Abstract
References
Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de Vigilância Epidemiológica. 7º edição - Cad. 12 pg. 32– Meningites. Departamento de Vigilância Epidemiológica – Brasília (DF); 2009.
Ministério da Saúde. Secretaria de Vigilância em Saúde. Introdução da vacina meningocócica C (conjugada) no calendário de vacinação da criança. Departamento de Vigilância Epidemiológica – Brasília (DF); 2010:1-18.
Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clinical Microbiology Reviews; 2006:142-64.
Trotter CL, Borrow R, Findlow J, Holland A, Frankland S, Andrews NJ, Miller E. Seroprevalence of antibodies against serogrup C meningococci in England in the posvaccination era. Clinical and vaccine immunology; 2008:1694-8.
Laurrari A, Cano R, García M, Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine. 2005;23(32):4097-100.
Borrow R, Miller E. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Expert Rev Vaccines. 2006;5(6):851-7.
Campbell H, Borrow R, Salisbury D, Miller E. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine. 2009;27(Suppl 2):B20-9.
Snape MD, Kelly DF, Lewis S, Banner C, Kibwana L, Moore CE, Diggle L, John T, Yu LM, Borrow R, Borkowski A, Nau C, Pollard AJ. Seroprotection against serogrup C meningococcal disease in adolescents in United Kingdom: observational study; BMJ 2008; 336:1487-91.
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococal serogroup C conjugate vaccine 4 years after introduction. Lancet, 2004; 364:365-7.
Sáfadi MA, Barros AP. Meningococcal conjugate vaccines: efficacy and new combinations. J Pediatr (RJ). 2006; 82(3 Suppl):S35-44.
Lakshman R,Jones I, Walker D, McMurtrie K, Shaw L, Race G, Choo S, Danzig L, Oster P, Finn A. Safety of new conjugate meningococcal C vaccine in infants, Arch Dis Child. 2001;85:391-7.
Southern J, Borrow R, Andrews N, Morris R, Waight P, Hudson M, et al. Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. Clin Vaccine Immunol. 2009;16(2):194-9.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2010 Divisão de Imunização, Divisão de Doenças de Transmissão Respiratórias